ArticleBlood advances2023

Durable responses with ALK inhibitors for primary refractory anaplastic lymphoma Kinase-positive large B-cell lymphoma.

Radhika Takiar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.